ABVC Amends $100M Shelf Registration While Cash Stands at $11,294
ABVC sits 41% above its 52-week low of $0.707 on light trading volume (0.1× avg).
Summary
ABVC filed a pre-effective amendment to its $100 million shelf registration, responding to SEC comments with no new securities registered and nothing sold. With $11,294 on hand and going-concern doubt, the shelf is the company's main route to raising cash.
Key Events · Financing and Capital Events · ABVC
-
Shelf Amendment Filed, No New Securities
Pre-Effective Amendment No. 1 to the Form S-3 (File No. 333-287512) responds to SEC comments; the prospectus covers up to $100,000,000 of common stock, preferred stock, warrants, subscription rights, debt securities and units, but no additional securities are registered and none have been sold.
-
I.B.6 Cap Limits Real Raise Size
Public float was $22,176,178 as of November 9, 2026 at a $1.02 close, so the one-third-of-float limit caps primary sales at roughly $7.4 million in any 12-month period while the float stays under $75 million.
-
Going-Concern Backdrop
The Q3 10-Q previously disclosed $11,294 of cash, a $5.79 million working capital deficit and going-concern doubt, cushioned only by the $3.39 million convertible note deal that closed October 30, 2026.
-
Share Count and Authorized Headroom
26,976,625 common shares were outstanding as of November 9, 2026 against 100,000,000 authorized, leaving substantial room for future issuance; 258,710 options and 1,475,800 warrants are also outstanding.
Analysis · ABVC · Life Sciences
ABVC has refreshed a $100 million shelf registration it first filed in May 2025, answering SEC comments without registering any new securities. Nothing has been sold and no terms are set — any actual raise needs a separate prospectus supplement. The size matters against the company's position: the Q3 10-Q disclosed $11,294 of cash, a $5.79 million working capital deficit and going-concern doubt, so this shelf is the mechanism the company would use to keep funding operations. Because the public float is $22.2 million, the one-third-of-float limit under General Instruction I.B.6 caps what can actually be sold in any 12-month window at roughly $7.4 million, far below the $100 million headline. The filing also puts 26,976,625 outstanding shares against 100,000,000 authorized, leaving room for large future issuance.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ABVC was trading at $1.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $26.8M. The 52-week trading range was $0.71 to $3.06. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.